New

Paediatric Vaccines Market

2021

Paediatric Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Monovalent, Multivalent); Vaccine Form (Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides, Conjugates); Application (Infectious disease, Allergy); End User (Hospitals, Pediatric Clinics, Academic and Research Organizations, Others) and Geography

| Report Code: TIPRE00003841 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Paediatric Vaccines Market 2028 By Type, Vaccine Form, Application, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Paediatric Vaccines are administered to children to help them stay away from several infectious disease such as, diphtheria, measles ,haemophilus Influenza and poliomyelitis. Apart from providing protection against infectious diseases, these vaccines also aid in the development of children's immune systems. Generally, paediatric vaccines are heat-killed or inactivated viruses that have lost their pathogenicity, or ability to cause disease. Furthermore, these inactivated antigens might trigger the immune system to create antibodies against the virus that has infected the body. As a result, they assist the immune system in future protection against infectious and non-infectious diseases.

MARKET SCOPE



The "Global Paediatric Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the paediatric vaccine market with detailed market segmentation by type, vaccine form, application and end user. The report provides key statistics on the market status of the leading paediatric vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on type the market is segmented as, monovalent and multivalent.
  • Based on vaccine form the market is segmented as, Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides and Conjugates.
  • Based on application the market is segmented as, infectious disease, allergy.
  • Based on end user the market is segmented as, Hospitals, Pediatric Clinics, Academic & Research Organizations and Others.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of chronic and infectious diseases in children.
  • Growing awareness about the benefits of vaccination for fighting against the disease.
  • Government initiatives for creating awareness for vaccination.
  • Extensive R&D activities to develop novel and innovative vaccines to fight paediatric infections and disorders is also expected to fuel the market growth.

Restraints:



  • However, high cost associated with development of vaccines, strict regulatory guidelines are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The paediatric vaccine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the paediatric vaccine market in these regions.

IMPACT OF COVID-19 ON PAEDIATRIC VACCINE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. The pharmaceutical and biopharmaceutical companies have focused their attention on developing effective vaccine against COVID-19 which is affecting the paediatric market a bit. This causing slowing down of production for other vaccines which is affecting the global paediatric vaccine market in large extent. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the paediatric vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from paediatric vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for paediatric vaccine in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the paediatric vaccine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Pfizer Inc.
  • Glaxosmithkline, Plc
  • Merck Sharp and Dohme Corp
  • Sanofi
  • Panacea Biotec Ltd
  • Sinovac Biotech
  • Bio Med Pvt. Ltd.
  • CSL Limited
  • Serum Institute of India Pvt. Ltd
  • Indian Immunologicals Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Paediatric Vaccines Market - By Type
1.3.2 Paediatric Vaccines Market - By Vaccine Form
1.3.3 Paediatric Vaccines Market - By Application
1.3.4 Paediatric Vaccines Market - By End User
1.3.5 Paediatric Vaccines Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PAEDIATRIC VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PAEDIATRIC VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PAEDIATRIC VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. PAEDIATRIC VACCINES - GLOBAL MARKET OVERVIEW
6.2. PAEDIATRIC VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PAEDIATRIC VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT
7.3.1. Overview
7.3.2. Monovalent Market Forecast and Analysis
7.4. MULTIVALENT
7.4.1. Overview
7.4.2. Multivalent Market Forecast and Analysis
8. PAEDIATRIC VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE FORM
8.1. OVERVIEW
8.2. VACCINE FORM MARKET FORECASTS AND ANALYSIS
8.3. ATTENUATED LIVE VIRUSES
8.3.1. Overview
8.3.2. Attenuated Live Viruses Market Forecast and Analysis
8.4. INACTIVATED VIRUSES
8.4.1. Overview
8.4.2. Inactivated Viruses Market Forecast and Analysis
8.5. SUBUNITS
8.5.1. Overview
8.5.2. Subunits Market Forecast and Analysis
8.6. TOXOIDS
8.6.1. Overview
8.6.2. Toxoids Market Forecast and Analysis
8.7. RECOMBINANT
8.7.1. Overview
8.7.2. Recombinant Market Forecast and Analysis
8.8. POLYSACCHARIDES
8.8.1. Overview
8.8.2. Polysaccharides Market Forecast and Analysis
8.9. CONJUGATES
8.9.1. Overview
8.9.2. Conjugates Market Forecast and Analysis
9. PAEDIATRIC VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INFECTIOUS DISEASE
9.3.1. Overview
9.3.2. Infectious disease Market Forecast and Analysis
9.4. ALLERGY
9.4.1. Overview
9.4.2. Allergy Market Forecast and Analysis
10. PAEDIATRIC VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. PEDIATRIC CLINICS
10.4.1. Overview
10.4.2. Pediatric Clinics Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH ORGANIZATIONS
10.5.1. Overview
10.5.2. Academic and Research Organizations Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis

11. PAEDIATRIC VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Paediatric Vaccines Market Overview
11.1.2 North America Paediatric Vaccines Market Forecasts and Analysis
11.1.3 North America Paediatric Vaccines Market Forecasts and Analysis - By Type
11.1.4 North America Paediatric Vaccines Market Forecasts and Analysis - By Vaccine Form
11.1.5 North America Paediatric Vaccines Market Forecasts and Analysis - By Application
11.1.6 North America Paediatric Vaccines Market Forecasts and Analysis - By End User
11.1.7 North America Paediatric Vaccines Market Forecasts and Analysis - By Countries
11.1.7.1 United States Paediatric Vaccines Market
11.1.7.1.1 United States Paediatric Vaccines Market by Type
11.1.7.1.2 United States Paediatric Vaccines Market by Vaccine Form
11.1.7.1.3 United States Paediatric Vaccines Market by Application
11.1.7.1.4 United States Paediatric Vaccines Market by End User
11.1.7.2 Canada Paediatric Vaccines Market
11.1.7.2.1 Canada Paediatric Vaccines Market by Type
11.1.7.2.2 Canada Paediatric Vaccines Market by Vaccine Form
11.1.7.2.3 Canada Paediatric Vaccines Market by Application
11.1.7.2.4 Canada Paediatric Vaccines Market by End User
11.1.7.3 Mexico Paediatric Vaccines Market
11.1.7.3.1 Mexico Paediatric Vaccines Market by Type
11.1.7.3.2 Mexico Paediatric Vaccines Market by Vaccine Form
11.1.7.3.3 Mexico Paediatric Vaccines Market by Application
11.1.7.3.4 Mexico Paediatric Vaccines Market by End User
11.1.7.4 US Paediatric Vaccines Market
11.1.7.4.1 US Paediatric Vaccines Market by Type
11.1.7.4.2 US Paediatric Vaccines Market by Vaccine Form
11.1.7.4.3 US Paediatric Vaccines Market by Application
11.1.7.4.4 US Paediatric Vaccines Market by End User
11.2. EUROPE
11.2.1 Europe Paediatric Vaccines Market Overview
11.2.2 Europe Paediatric Vaccines Market Forecasts and Analysis
11.2.3 Europe Paediatric Vaccines Market Forecasts and Analysis - By Type
11.2.4 Europe Paediatric Vaccines Market Forecasts and Analysis - By Vaccine Form
11.2.5 Europe Paediatric Vaccines Market Forecasts and Analysis - By Application
11.2.6 Europe Paediatric Vaccines Market Forecasts and Analysis - By End User
11.2.7 Europe Paediatric Vaccines Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Paediatric Vaccines Market
11.2.7.1.1 Germany Paediatric Vaccines Market by Type
11.2.7.1.2 Germany Paediatric Vaccines Market by Vaccine Form
11.2.7.1.3 Germany Paediatric Vaccines Market by Application
11.2.7.1.4 Germany Paediatric Vaccines Market by End User
11.2.7.2 France Paediatric Vaccines Market
11.2.7.2.1 France Paediatric Vaccines Market by Type
11.2.7.2.2 France Paediatric Vaccines Market by Vaccine Form
11.2.7.2.3 France Paediatric Vaccines Market by Application
11.2.7.2.4 France Paediatric Vaccines Market by End User
11.2.7.3 Italy Paediatric Vaccines Market
11.2.7.3.1 Italy Paediatric Vaccines Market by Type
11.2.7.3.2 Italy Paediatric Vaccines Market by Vaccine Form
11.2.7.3.3 Italy Paediatric Vaccines Market by Application
11.2.7.3.4 Italy Paediatric Vaccines Market by End User
11.2.7.4 Spain Paediatric Vaccines Market
11.2.7.4.1 Spain Paediatric Vaccines Market by Type
11.2.7.4.2 Spain Paediatric Vaccines Market by Vaccine Form
11.2.7.4.3 Spain Paediatric Vaccines Market by Application
11.2.7.4.4 Spain Paediatric Vaccines Market by End User
11.2.7.5 United Kingdom Paediatric Vaccines Market
11.2.7.5.1 United Kingdom Paediatric Vaccines Market by Type
11.2.7.5.2 United Kingdom Paediatric Vaccines Market by Vaccine Form
11.2.7.5.3 United Kingdom Paediatric Vaccines Market by Application
11.2.7.5.4 United Kingdom Paediatric Vaccines Market by End User
11.2.7.6 Rest of Europe Paediatric Vaccines Market
11.2.7.6.1 Rest of Europe Paediatric Vaccines Market by Type
11.2.7.6.2 Rest of Europe Paediatric Vaccines Market by Vaccine Form
11.2.7.6.3 Rest of Europe Paediatric Vaccines Market by Application
11.2.7.6.4 Rest of Europe Paediatric Vaccines Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Paediatric Vaccines Market Overview
11.3.2 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis
11.3.3 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis - By Vaccine Form
11.3.5 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Paediatric Vaccines Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Paediatric Vaccines Market
11.3.7.1.1 Australia Paediatric Vaccines Market by Type
11.3.7.1.2 Australia Paediatric Vaccines Market by Vaccine Form
11.3.7.1.3 Australia Paediatric Vaccines Market by Application
11.3.7.1.4 Australia Paediatric Vaccines Market by End User
11.3.7.2 China Paediatric Vaccines Market
11.3.7.2.1 China Paediatric Vaccines Market by Type
11.3.7.2.2 China Paediatric Vaccines Market by Vaccine Form
11.3.7.2.3 China Paediatric Vaccines Market by Application
11.3.7.2.4 China Paediatric Vaccines Market by End User
11.3.7.3 India Paediatric Vaccines Market
11.3.7.3.1 India Paediatric Vaccines Market by Type
11.3.7.3.2 India Paediatric Vaccines Market by Vaccine Form
11.3.7.3.3 India Paediatric Vaccines Market by Application
11.3.7.3.4 India Paediatric Vaccines Market by End User
11.3.7.4 Japan Paediatric Vaccines Market
11.3.7.4.1 Japan Paediatric Vaccines Market by Type
11.3.7.4.2 Japan Paediatric Vaccines Market by Vaccine Form
11.3.7.4.3 Japan Paediatric Vaccines Market by Application
11.3.7.4.4 Japan Paediatric Vaccines Market by End User
11.3.7.5 Rest of Asia-Pacific Paediatric Vaccines Market
11.3.7.5.1 Rest of Asia-Pacific Paediatric Vaccines Market by Type
11.3.7.5.2 Rest of Asia-Pacific Paediatric Vaccines Market by Vaccine Form
11.3.7.5.3 Rest of Asia-Pacific Paediatric Vaccines Market by Application
11.3.7.5.4 Rest of Asia-Pacific Paediatric Vaccines Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Paediatric Vaccines Market Overview
11.4.2 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis
11.4.3 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis - By Vaccine Form
11.4.5 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Paediatric Vaccines Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Paediatric Vaccines Market
11.4.7.1.1 South Africa Paediatric Vaccines Market by Type
11.4.7.1.2 South Africa Paediatric Vaccines Market by Vaccine Form
11.4.7.1.3 South Africa Paediatric Vaccines Market by Application
11.4.7.1.4 South Africa Paediatric Vaccines Market by End User
11.4.7.2 Saudi Arabia Paediatric Vaccines Market
11.4.7.2.1 Saudi Arabia Paediatric Vaccines Market by Type
11.4.7.2.2 Saudi Arabia Paediatric Vaccines Market by Vaccine Form
11.4.7.2.3 Saudi Arabia Paediatric Vaccines Market by Application
11.4.7.2.4 Saudi Arabia Paediatric Vaccines Market by End User
11.4.7.3 U.A.E Paediatric Vaccines Market
11.4.7.3.1 U.A.E Paediatric Vaccines Market by Type
11.4.7.3.2 U.A.E Paediatric Vaccines Market by Vaccine Form
11.4.7.3.3 U.A.E Paediatric Vaccines Market by Application
11.4.7.3.4 U.A.E Paediatric Vaccines Market by End User
11.4.7.4 Rest of Middle East and Africa Paediatric Vaccines Market
11.4.7.4.1 Rest of Middle East and Africa Paediatric Vaccines Market by Type
11.4.7.4.2 Rest of Middle East and Africa Paediatric Vaccines Market by Vaccine Form
11.4.7.4.3 Rest of Middle East and Africa Paediatric Vaccines Market by Application
11.4.7.4.4 Rest of Middle East and Africa Paediatric Vaccines Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Paediatric Vaccines Market Overview
11.5.2 South and Central America Paediatric Vaccines Market Forecasts and Analysis
11.5.3 South and Central America Paediatric Vaccines Market Forecasts and Analysis - By Type
11.5.4 South and Central America Paediatric Vaccines Market Forecasts and Analysis - By Vaccine Form
11.5.5 South and Central America Paediatric Vaccines Market Forecasts and Analysis - By Application
11.5.6 South and Central America Paediatric Vaccines Market Forecasts and Analysis - By End User
11.5.7 South and Central America Paediatric Vaccines Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Paediatric Vaccines Market
11.5.7.1.1 Brazil Paediatric Vaccines Market by Type
11.5.7.1.2 Brazil Paediatric Vaccines Market by Vaccine Form
11.5.7.1.3 Brazil Paediatric Vaccines Market by Application
11.5.7.1.4 Brazil Paediatric Vaccines Market by End User
11.5.7.2 Argentina Paediatric Vaccines Market
11.5.7.2.1 Argentina Paediatric Vaccines Market by Type
11.5.7.2.2 Argentina Paediatric Vaccines Market by Vaccine Form
11.5.7.2.3 Argentina Paediatric Vaccines Market by Application
11.5.7.2.4 Argentina Paediatric Vaccines Market by End User
11.5.7.3 Rest of South and Central America Paediatric Vaccines Market
11.5.7.3.1 Rest of South and Central America Paediatric Vaccines Market by Type
11.5.7.3.2 Rest of South and Central America Paediatric Vaccines Market by Vaccine Form
11.5.7.3.3 Rest of South and Central America Paediatric Vaccines Market by Application
11.5.7.3.4 Rest of South and Central America Paediatric Vaccines Market by End User

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. PAEDIATRIC VACCINES MARKET, KEY COMPANY PROFILES
13.1. PFIZER INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE, PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MERCK SHARP AND DOHME CORP
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PANACEA BIOTEC LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SINOVAC BIOTECH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BIO MED PVT. LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CSL LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SERUM INSTITUTE OF INDIA PVT. LTD
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. INDIAN IMMUNOLOGICALS LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
"
The List of Companies

- Pfizer Inc.
- Glaxosmithkline, Plc
- Merck Sharp and Dohme Corp
- Sanofi
- Panacea Biotec Ltd
- Sinovac Biotech
- Bio Med Pvt. Ltd.
- CSL Limited
- Serum Institute of India Pvt. Ltd
- Indian Immunologicals Ltd
- Grifols
- Emergent BioSolutions Inc
TIPRE00003841
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.